Skip to content
Wednesday 12 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE
MorningWire

European business, markets and politics

FTSE 100
10,833.15
-0.10%
DAX
26,331.07
-0.23%
CAC 40
8,674.94
-0.46%
STOXX 50
6,533.99
-0.26%
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
More
GermanyFranceBankingAIEnergyFintechPropertyCapital Markets
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Technology
  • Politics
  • Opinion
  • DE
Sunday 22 August 2021 4:13 pm  |  Updated:  Thursday 11 November 2021 11:33 am

Critically-ill Covid patients far less likely to die when lying on stomach while receiving oxygen

By: Michiel Willems

Add as a preferred source on Google

Critically-ill Covid-19 patients are far less likely to pass away or to require invasive ventilation if they are lying on their stomachs while receiving oxygen, according to a new global study.

The impact of the technique, known as awake prone positioning, was assessed in hospitals in six countries and involved more than 1,000 coronavirus patients requiring advanced breathing support.

The findings of the study, sponsored by NUI Galway, have been published in The Lancet Respiratory Medicine.

It was the first clinical trial of its kind into the practice of awake prone positioning and ran from April 2020 to January 2021.

It showed that putting patients in this position while they received high flow nasal cannula oxygen reduced death and the need for invasive mechanical ventilation.

Dr Bairbre McNicholas, honorary senior lecturer at NUI Galway and intensive care consultant at University Hospital Galway, said: “Providing an evidence base for what we do in the intensive care unit is critical so that we support and implement recommendations that work.

“This study, which was part of a global effort and was sponsored locally by NUI Galway and the Health Research Board Clinical Research Facility Galway, as part of its response to the Covid-19 pandemic, shows that clinical trials can be scaled up and done properly and efficiently during a pandemic and demonstrates what we can achieve when we work together.”

Read more

Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

Global study

The study involved 1,121 patients in the US, Canada, Mexico, France, Spain and Ireland, and it is the first time awake prone positioning has been studied to such an extent.

Some of the key findings of the study include that the wake prone positioning reduces death and the need for invasive intubation in patients with severe Covid-19 who require high flow nasal cannula oxygen.

The technique is safe and well-tolerated by patients and blood oxygen levels are significantly improved in patients who adopt awake prone positioning.

The longer patients can sustain being in prone positioning, the greater the success of the treatment and the less likely they are to need invasive mechanical ventilation.

Dr McNicholas said: “I tell patients that going on your tummy will improve the oxygen levels in your blood, that, although it is uncomfortable, the longer you can put up with this position, the less likely you will need to go on to require needing a breathing tube.”

Lisa Power was treated using awake prone positioning while a Covid patient at University Hospital Galway.

She said: “It really helped my breathing and made me much more comfortable without having to put me on a ventilator.”

Read more

Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Business

Related Topics

  • Coronavirus
  • Pharmaceuticals

Trending Articles

  • Five-star Mayfair hotel hit with HMRC winding-up petition

  • Nottingham Forest owner Marinakis sues Crystal Palace for defamation

  • Back to basics: Sainsbury’s gradual retreat from the British high street

  • It’s not just Jason Arday, most of sociology is a scam

  • Hargreaves Lansdown orders staff back to office

More from Morning Wire

  • Dompé Doses First Patient in Phase 3 Study of Cenegermin-bkbj in NAION

    Business Wire
  • Leo Cancer Care Raises $65M Series D to Scale Its Integrated Upright Cancer Care Platform

    Business Wire
  • Verdiva Bio Initiates Phase 1 Study of VRB-103, a Selective Oral Amylin Peptide Analog With Weekly Dosing Potential

    Business Wire
  • Silence Therapeutics Announces Positive Topline Results from Phase 2 SANRECO Trial of Divesiran in Polycythemia Vera, Supporting its Potential Best-in-Class Profile

    Business Wire
  • Ignore Palantir’s political opponents and look at the data: this technology helps patients

    Opinion
    NHS logo on a white surface with visible water droplets, blue and white branding
  • Almirall Announces EMA Acceptance for Filing of Paediatric Registration of Ebglyss (Lebrikizumab) in Atopic Dermatitis in Children 6 Months and Older

    Business Wire
  • NHS data counters claims that £330m Palantir deal has led to ‘no improvement’

    Tech
    Brit are seeking financial support from the ‘Bank of Mum and Dad’ to afford private healthcare.
  • Alkermes’ Alixorexton Demonstrated Sustained Improvement in Wakefulness in Adults With Narcolepsy Type 1 and Type 2 in Long-Term Extension Study Interim Analysis

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • Europe
  • UK & Ireland

Business

  • Markets
  • Banking
  • Technology
  • Energy
  • Property
  • Fintech

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook